Berkshire Hathaway (HAM:BRYN) Research & Development: €0 Mil (TTM As of Mar. 2026)


HAM:BRYN Berkshire Hathaway Inc HAM:BRYN
71 GF Score
Price €435.00
GF Value €465.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Berkshire Hathaway Research & Development?

Berkshire Hathaway HAM:BRYN +0.44% 71 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates HAM:BRYN with a GF Score™ of 71/100 and a GF Value™ of €465.49 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Berkshire Hathaway's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Berkshire Hathaway  (HAM:BRYN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Berkshire Hathaway Research & Development Related Terms

Berkshire Hathaway Research & Development Historical Data

* Premium members only.

The historical data trend for Berkshire Hathaway's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Berkshire Hathaway Research & Development Chart

Berkshire Hathaway Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Berkshire Hathaway Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HAM:BRYN
71GF Score
Berkshire Hathaway Inc HAM:BRYN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Berkshire Hathaway Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Berkshire Hathaway (HAM:BRYN) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Berkshire Hathaway and its competitors.
Is Berkshire Hathaway's Research & Development too high?
Berkshire Hathaway's current Research & Development is €0 Mil. Overall, Berkshire Hathaway has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Berkshire Hathaway's Research & Development compare to AIG and HIG?
Berkshire Hathaway's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Berkshire Hathaway and its competitors. Berkshire Hathaway's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Berkshire Hathaway stock overvalued right now?
Based on GuruFocus' analysis, Berkshire Hathaway (HAM:BRYN) is currently considered Fairly Valued. The stock's GF Value™ is €465.49, compared to a current price of €435.00 — trading 6.6% below its estimated fair value. The current Research & Development is €0 Mil. Berkshire Hathaway's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Berkshire Hathaway (HAM:BRYN), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Berkshire Hathaway (HAM:BRYN) Overvalued in 2026?

Based on GuruFocus' analysis, Berkshire Hathaway stock appears to be undervalued. The current stock price of €435.00 is trading 6.6% below its estimated GF Value™ of €465.49. GuruFocus considers Berkshire Hathaway to be Fairly Valued.

Key valuation signals for HAM:BRYN:

  • Research & Development: €0 Mil
  • GF Value™: €465.49 vs. price of €435.00 (6.6% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the HAM:BRYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Berkshire Hathaway Business Description

Address 3555 Farnam Street, Omaha, NE, USA, 68131
Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from its operations to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the companies that make up its manufacturing, service, and retailing operations (which include Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis. Berkshire generated close to $371.4 billion in operating revenue in during 2025.
71GF Score

Get the complete analysis for HAM:BRYN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€435.00
Price
€465.49
GF Value